GLP-1 agonists and the dental patient: sedation risk, dry mouth, and the gaps in the oral-health data

Details

Semaglutide is reshaping patient physiology faster than dentistry's evidence base; we collect the aspiration-risk and xerostomia signals and mark where guidance is still guesswork.

QA notes: Copy written. Formats not picked and no imagery rendered, so not approvable yet. Built 8 slides, ~1115 words. Content model and report written. Imagery pending.

Format: — · Created 06 Jun 2026

Status: generated — assets built and QA-passed, awaiting approval to schedule/post. Nothing here is published yet.